Gilead Sciences, Inc. logo

Gilead Sciences

GILD

Healthcare
NASDAQ
US

About Gilead Sciences

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truv…

Power Profile

Revenue Counter

Gilead Sciences earns $933.60/sec (TTM: $29.44B)

Revenue counter

Earnings Counter

Gilead Sciences earns $269.85/sec net profit (TTM: $8.51B)

Earnings counter

Economic Scale

Gilead Sciences revenue exceeds Albania GDP ($27.0B)

Economic scale

What If Invested

See what $1,000 invested in Gilead Sciences would be worth today

What if invested

How it makes money

Visual revenue breakdown: how Gilead Sciences generates income and where it flows

How it makes money

Seasonality

Monthly and quarterly returns heatmap, seasonality matrix for Gilead Sciences

View seasonality
Q1 2026
Report Date
Apr 23, 2026
AMC
Lock in
37 days
Revenue
Analyst Forecast
$6.92B
EPS
Analyst Forecast
1.91
Q4 2025
Report Date
Feb 10, 2026
AMC
Lock in
Locked
Revenue
Actual
$7.92B
Analyst Forecast
$7.68B
EPS
Actual
1.86
Analyst Forecast
1.85